logo
Search…
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Search...
search
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Home > Latest

Lates News

date
03/02/2026
A Pfizer executive stated that the goal is to obtain the first approval for a series of potential obesity drugs in 2028.
Latest
5 m ago
Ant Financial CEO sent a letter to all employees, announcing the establishment of a "Large Model Technology Innovation Department".
6 m ago
Disney stated that Ed will serve as a senior consultant.
6 m ago
Disney appoints theme park head Josh D'Amaro as CEO.
7 m ago
Intercontinental Exchange Group: Getting ready to launch repurchase agreement clearing business later this year.
8 m ago
According to AI Express, Dongwu Securities issued a research report on February 3, giving Jinhuaxin Materials (920015.SH) a "buy" rating. The main reasons for the rating include: 1) A high-quality supplier in the ketone oxime industry; 2) The market size of hydroxylamine salts is rising, and the downstream market industry is expanding; 3) Strong technological innovation capabilities and abundant high-quality customer resources. (Daily Economic News)
See all latestmore
logo
Contact US
qr
+852 - 60190728
[email protected]
Customer Support
About Us
Contact Us
Frequently Asked
Privacy Policy
Terms of Use
Commercial Services
Advertising
Business Development
Copyright
Terms of Service
©️2013 - 2026 GMT EIGHT Holdings. All Rights Reserved.